CRL · News · 20260805N
Capital Return Program
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. · 2026-08-05 · Importance 58 · Surprise 42 · In source text
Charles River repurchased $100.0 million of common stock during Q2 2026. Total repurchases reached $300.0 million year to date. The buybacks provided a material offset to dilution and represented the company’s disclosed capital allocation during the quarter. No dividend declaration was reported in the digest.
Key facts
- The company repurchased $100.0 million of stock in Q2 2026 and $300.0 million year-to-date. source
Impact estimates
| metric | direction | stage | expected | basis |
|---|---|---|---|---|
| cash | negative | realized | — | The company repurchased $100.0 million of stock in Q2 2026 and $300.0 million year-to-date. |